In The News

End of Health Crisis Will Put Heaps of Covid Products in Limbo

Bloomberg Law

21 Jul 2021

Stacy Cline Amin, former Chief Counsel of the Food and Drug Administration, spoke with Bloomberg Law about how FDA might transition more than 400 products from emergency use status to approved status, if the public health emergency with COVID-19 ends.

“The sheer volume of authorized products could be potentially very disruptive, if not transitioned well by FDA,” said Stacy. “FDA is aware of that and thinking about it.”

The emergency also may not go away anytime soon, with the emergence of new variants and as the pandemic continues to rage globally, Amin noted.

“It may not be the case that the public health emergency for us is really, you know, coming to a quick close,” she said.

Read the full article (subscription required).

Close
Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.